Business
Teva will pay Eagle $30 million upfront and up to $90 million in milestone payments.
Hi, what are you looking for?
Jewish Business News
Business
Israeli Icecure Gets $21.2 Million International Investment to Treat Breast Cancer with Extreme Cold
Cryoablation has been used for years in medical applications such as dermatology, kidney, prostate and liver, to treat both cancerous and non-cancerous tumors.
Business
Teva says that the move is designed to reduce its finance costs.
Business
"This patent allowance in Israel further extends the geographic reach of our intellectual property."
Business
Following the resignation of Alfred Mann as CEO and the announcement of a large payment from partner Sanofi, and ahead of the launch of...
Business
Israel’s Micromedic Technologies which specializes in the development and commercialization of cancer diagnostic products announced the results of a blinded, multi-center clinical study using...
Business
PhotoMedex Inc. (Nasdaq: PHMD; TASE: PHMD) has announced the sale of its LCA-Vision subsidiary to Vision Acquisition for $40 million in cash. PhotoMedex bought...
Business
J&J will help get regulatory approval for InsuPad, which reduces injected insulin uptake speed in diabetics by nearly 50%. The share of...
Business
Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, reported it has received positive...
Business
The Hebrew University tech transfer company will collaborate on a novel delivery system. Hebrew University of Jerusalem technology transfer company Yissum Research Development Co....